Key Insights

Highlights

Treatment Research

1 treatments under study, led by Fei Re Qing Granules

Research Leaders

6 sponsors active, led by Henan University of Traditional Chinese Medicine

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Research Network

Common Treatments

  • Fei Re Qing Granules1

Active Sponsors

  • Henan University of Traditional Chinese Medicine1
  • Henan Provincial People's Hospital1
  • The First Affiliated Hospital of Henan University of Traditional Chinese Medicine1
  • The First Affiliated Hospital of Zhengzhou University1
  • Third Affiliated Hospital of Henan University of Traditional Chinese Medicine1

Top Investigators

  • The First Affiliated Hospital of Henan University of Traditional Chinese Medicine

Activity Timeline